THE VASCULAR SOCIETY
The objects of the Society are to relieve sickness and to preserve, promote and protect the health of the public in Great Britain, Ireland and the world by advancing for the public benefit, the science and art of, and research into the treatment of vascular disorders, and promoting or conducting or causing to be carried out or fund all types of research relevant to vascular disease.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net deficit of £123,046 for the year ended 30 June 2025, reversing a previous decline in Annual Scientific Meeting profits. Per the trustees' report, unrestricted free reserves stood at £790,372, which exceeds the stated policy target of £600,000, providing a buffer against the loss of previous industry funding sources.
What the accounts disclose
“the desirable reserve for the above objectives has been calculated as £600,000”
“The charity has a wholly owned trading subsidiary which is incorporated in the United Kingdom, VSGBI Limited (registered number 04020415)” — page 8
Structured financials (annual return, FY ending 30/06/2025)
Trustees
- Andrew Roger Alleyn Thompson
- Anselm Asehasem Egun
- Christopher Paul Twine
- Colin Bicknell
- Daniel Carradice
- Dr Sadasivam SELVAKUMAR
- James McCaslin
- Jonathan Ghosh
- Kaji Sritharan
- Keith Gordon Jones
- Marco Luigi Baroni
- Marcus John Brooks
- Patrick Coughlin
- Patrick Neil Thomas Lintott
- Paul William Moxey
- Professor Athanasios Saratzis
- Professor Srinivasa Rao Vallabhaneni
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/06/2025 | £590k | £718k |
| 30/06/2024 | £958k | £1.1m |
| 30/06/2023 | £797k | £693k |
| 30/06/2022 | £861k | £681k |
| 30/06/2021 | £307k | £310k |
Common questions
Is THE VASCULAR SOCIETY financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net deficit of £123,046 for the year ended 30 June 2025, reversing a previous decline in Annual Scientific Meeting profits. Per the trustees' report, unrestricted free reserves stood at £790,372, which exceeds the stated policy target of £600,000, providing a buffer against the loss of previous industry funding sources. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| G M MORRISON CHARITABLE TRUST | 1 | £3k |
Charities like this
- EUROPEAN SOCIETY FOR VASCULAR SURGERY
- THE PATHOLOGICAL SOCIETY OF GREAT BRITAIN AND IRELAND
- THE BRITISH BLOOD TRANSFUSION SOCIETY
- ROYAL STATISTICAL SOCIETY
- THE MEDICAL SOCIETY OF LONDON
- HEALTHCARE INFECTION SOCIETY
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE VASCULAR SOCIETY | £590k | — | 0 | unclear | — | no doubt |
| EUROPEAN SOCIETY FOR VASCULAR SURGERY | £2.5m | more than €70,000 | 1 | unclear | — | no doubt |
| THE PATHOLOGICAL SOCIETY OF GREAT BRITAIN AND IRELAND | £1.5m | — | 0 | above | — | no doubt |
| THE BRITISH BLOOD TRANSFUSION SOCIETY | £290k | — | 0 | unclear | — | no doubt |
| ROYAL STATISTICAL SOCIETY | £2.3m | unclear | — | unclear | — | no doubt |
| THE MEDICAL SOCIETY OF LONDON | £221k | — | 0 | unclear | — | no doubt |